Fuller & Thaler Asset Management’s Veracyte VCYT Stock Holding History

Fuller & Thaler Asset Management’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$45.6M	Buy	1,414,362 +32,925	+2%	+$1.22M	0.15%	209
2025 Q4	$58.2M	Buy	+1,381,437	New	+$55.7M	0.2%	184
2023 Q1	–	Sell	-372,185	Closed	-$8.83M	–	547
2022 Q4	$8.83M	Buy	+372,185	New	+$8.65M	0.06%	224
2019 Q3	–	Sell	-103,040	Closed	-$2.94M	–	493
2019 Q2	$2.94M	Sell	103,040 -51,152	-33%	-$1.28M	0.03%	246
2019 Q1	$3.86M	Buy	154,192 +4,680	+3%	+$89.4K	0.05%	209
2018 Q4	$1.88M	Buy	+149,512	New	+$1.77M	0.03%	274

Other funds holding VCYT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Fuller & Thaler Asset Management's VCYT Position: Q1 2026 in Review

Fuller & Thaler Asset Management increased its Veracyte (VCYT) stake by 2.4% in Q1 2026, buying an estimated $1.22M and bringing the position to 1,414,362 shares worth $45.6M. The position accounts for 0.15% of the portfolio, ranked #209.

Fuller & Thaler Asset Management first reported a position in VCYT in Q4 2018 and has held it in 6 quarters since. The position peaked at $58.2M in Q4 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

Fuller & Thaler Asset Management held 1,414,362 shares of Veracyte worth $45.6M as of Q1 2026.
Fuller & Thaler Asset Management bought 32,925 Veracyte shares in Q1 2026, an estimated $1.22M.
Veracyte made up 0.15% of Fuller & Thaler Asset Management's portfolio in Q1 2026, its #209 holding.
Fuller & Thaler Asset Management first reported a position in Veracyte in Q4 2018 and has held it in 6 quarters since.
Fuller & Thaler Asset Management's Veracyte position peaked at $58.2M in Q4 2025.
334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Fuller & Thaler Asset Management's 13F filing for Q1 2026, filed 14 May 2026.